Company intelligence / Profile preview

Puyi Biotech

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Puyi Biotech is a Chinese life sciences company specializing in the development of fourth-generation nanopore sequencing technology. The company focuses on creating high-throughput, high-accuracy sequencing platforms for DNA, RNA, and protein analysis. Their technology aims to provide real-time, long-read sequencing solutions for applications in clinical diagnostics, pathogen detection, and basic biological research. Puyi Biotech has successfully developed proprietary nanopore sensors and integrated sequencing systems to compete in the global genomics market.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Nanopore sequencingDevice
Industry: Molecular Diagnostics

Partnerships

Guangzhou Laboratory

Beyond the preview

Go deeper on Puyi Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puyi Biotech.

Explore the full profile